HIV Infographic: Real-time Patient Insights from Medisafe
Highlights from the HIV Infographic
- The U.S. trails other nations in reported HIV adherence on Medisafe
- Those on HIV meds are adherent all week long, with Fridays and Saturdays showing slight dips
- Unlike many therapeutic areas, HIV medication adherence peaks three times daily – in the early morning, 6 pm, and late-night hours
- Adherence on Medisafe peaks for the 40-50 year age group
- Across various med classes, ViiV and Gilead have six of the top 10 highest adherence HIV medications reported on Medisafe
What insights can we discover about your brand? Contact us to find out!
Full HIV Adherence Insights
Most Adherent Countries For HIV Meds
- Canada: 89%
- Mexico: 88%
- Spain: 88%
- Germany: 87%
- UK: 87%
- Australia: 86%
- France: 86%
- Brazil: 85%
- USA: 83%
How Day Of Week Affect HIV Med Adherence
- Sunday: 86%
- Monday: 86%
- Tuesday: 86%
- Wednesday: 85%
- Thursday: 85%
- Friday: 84%
- Saturday: 84%
Adherence Rates By Age Range
- <20: 84%
- 20-30: 85%
- 30-40: 87%
- 40-50: 88%
- 50-60: 85%
- 60+: 87%
Adherence Rates by HIV Med Classification
- NNRTIs: 85%
- Protease Inhibitors: 84%
- Combination HIV Medication: 83%
- NRTIs: 79%
Top HIV Meds With Highest Adherence
| Brand | Company | Adherence |
| Sustiva (efavirenz) | Bristol-Myers Squibb | 87% |
| Viread (tenofovir) | Gilead | 86% |
| Triumeq (dolutegravir + abacavir + lamivudine) | ViiV Healthcare | 85% |
| Tivicay (dolutegravir) | ViiV Healthcare | 85% |
| Reyataz (atazanavir) | Bristol-Myers Squibb | 85% |
| Stribild (Emtriva + Viread + elvitegravir) | Gilead | 83% |
| Norvir (ritonavir) | AbbVie | 83% |
| Epivir (lamivudine, “3TC”) | ViiV Healthcare | 83% |
| Genvoya (elvitegravir) | Gilead | 83% |
| Kaletra (lopinavir) | AbbVie | 82% |